ENTX
Entera Bio Ltd
2.70$
+0.0%
vs. previous close
Closing price · As of: Sep 29, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | |
| – | +25.0% | +22.9% | +25.6% | +340.7% | -73.5% | -15.9% | +20.8% | -12.5% | -17.9% | -34.8% | |
| – | +307.1% | +227.9% | -74.8% | +20.3% | -39.2% | +106.5% | +20.7% | -24.8% | +51.3% | +7.6% | |
| – | -386.0% | – | -85.1% | +13.5% | -140.1% | – | +41.0% | – | – | – | |
| – | – | +157.5% | -155.7% | – | -150.8% | – | -230.2% | – | – | +1,022.3% | |
| – | -24.1% | +24.4% | +33.3% | -41.2% | +32.5% | -67.9% | +176.5% | -63.8% | -82.4% | +3,466.7% | |
| – | +1,966.7% | – | -506.0% | – | -101.3% | -67.9% | +500.0% | -83.3% | -82.4% | +3,466.7% | |
| – | – | – | -20.4% | +32.6% | – | – | – | – | – | – | |
| – | +259.9% | -113.6% | -88.4% | +0.0% | +19.3% | – | – | – | – | – | |
| – | +61.6% | +53.9% | -13.4% | +31.5% | -68.0% | +526.5% | -99.9% | +46,330.8% | -25.8% | +206.3% | |
| – | +223.3% | +156.4% | -155.9% | – | -185.4% | – | -177.2% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – |
Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.